About Checkin
Nobody should be alone on their GLP-1 journey.
Checkin is a free texting companion that's there between GLP-1 shots and appointments, so you never have to figure it out alone.
Support hasn't kept up.
About 1 in 9 American adults take a GLP-1 to lose weight, up from 1 in 33 in 2024. Most get a prescription and a short visit, and then they're on their own with the nausea, the shot-day nerves and the questions at 11 pm.
That gap matters. In a study of more than 125,000 people who started a GLP-1, about 2 in 3 without diabetes stopped within a year. Side effects and cost are the main reasons.
American adults take a GLP-1 to lose weight
Up from 1 in 33 in 2024
Source: Gallup, July 2026
people who started a GLP-1 to lose weight stopped within 12 months
In a study of more than 125,000 people who started a GLP-1
Source: JAMA Network Open, 2025
Good help shouldn't be hard to find.
Most of what's out there is selling something, written for doctors, or a guess in a comment thread. Trustworthy help shouldn't depend on what you can pay or who you know.
So we made it free. For everyone on a GLP-1.
Meet Checkin.
A companion you text, the same way you'd text a friend.
- 1It reaches out.A couple of days after your shot, it texts to ask how you're doing. A rough week gets noticed early, not at your next appointment.
- 2It answers.Any question, any hour, in plain English. Every answer comes from trusted, cited medical sources.
- 3It keeps track.Your shots, meals and weight, logged just by texting. Your next appointment starts with the full picture.
- 4It knows its limits.Warning signs always get “call your doctor or 911.” It's an AI companion, not a doctor, and it says so.
What changes for you.
Fewer surprises, fewer late-night worries, better conversations with your doctor, and more help sticking with the plan you and your prescriber chose.
Our promises.
Free. We never charge you to use Checkin.
Private. We never sell or share your texts.
Sourced. Every answer cites its source, such as FDA drug labels, MedlinePlus and the CDC.
Checkin isn't medical advice and doesn't replace your care team. Privacy policy · Medical disclaimer
We're just getting started.
Millions more people will start a GLP-1 in the next few years, with new pills and new medications arriving all the time. We want everyone to have trustworthy help, one text away.
To your health, The Checkin team
Meet the team.
- James CoholanLead Product Manager

- Bryant HigaDigital Marketing Specialist

- Mason ChambersLead Product Engineer

- Christian FeilerSenior Product Manager

- David LaneProduct Manager

- Sally LiuLead Product Designer

Checkin, Inc.
Los Angeles, California
Sources: Gallup, July 2026 (GLP-1 use among U.S. adults); JAMA Network Open, 2025 (people who stopped a GLP-1 within a year).